After a blockbuster IPO, is the Oxford Nanopore share price too expensive?

Rupert Hargreaves takes a look at the Oxford Nanopore share price – after one of the hottest IPOs of 2021 – to see if he’s missed the boat.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Oxford Nanopore (LSE: ONT) share price jumped a staggering 47% after the company’s IPO yesterday, as investors rushed to buy one of the hottest IPOs of 2021.

The DNA sequencing organisation’s technology has been essential in tracking Covid-19 variants globally over the past two years. Its range of devices for DNA and RNA sequencing has also been used in monitoring the spread of Ebola and Zika in recent years. The demand for these tools is only expanding, but this isn’t the only string to the group’s bow. 

At present, the group’s tech is mainly used by universities and labs conducting scientific research. However, it’s looking to tap into the growing genomic sequencing market, estimated to be worth $5.7bn globally.

Management thinks there’s enormous potential for the technology in markets such as infectious disease, immune profiling and cancer diagnostics. Food safety and agriculture could also offer markets for Oxford Nanopore’s technology. 

With such blue-sky potential, I can see why the Oxford Nanopore share price reacted so positively at the IPO. But I want to know if there’s still room for the stock to grow from here, or has the market got ahead of itself? 

Revenue potential 

According to the company’s pre-IPO prospectus, its revenues have grown at a staggering compound annual rate of more than 50% over the past year. And it looks as if this growth’s going to continue in 2021. 

For the six months ended 30 June, the firm’s revenues hit nearly £59m, up from £48m in the prior-year period. Unfortunately, Oxford Nanopore’s still investing heavily in research and development. So, as revenues have expanded, so have operating costs. As a result, the loss before tax increased from £42m in the first six months of 2020 to £44m for the first six months of 2021. 

This makes it quite challenging for me to value the enterprise. Without any income, I can’t calculate how much the enterprise could be worth on profits alone. 

A strategy I can use to value a loss-making stock like the Oxford Nanopore share price is to use the price-to-sales (P/S) multiple. On this basis, I estimate the stock’s selling at a P/S ratio of around 56. That seems very high to me. According to my analysis, the company’s international peers are trading at multiples of 10, or less. 

That said, it’s also impossible for me to value future growth at this stage. If the company can break into new markets, then the stock could be worth the higher valuation. Especially if sales take off over the next few years.

Oxford Nanopore share price opportunity 

Considering all of the above, I think the company has enormous potential. But right now, the stock looks too pricey for me. However, it may be suitable for investors with more experience in the sector and a higher risk tolerance. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£21,392 to invest in an ISA? Consider UK shares for a turbocharged retirement

Saving rather than investing? Let me explain why putting money in a savings account instead of UK shares could be…

Read more »

Illustration of flames over a black background
Investing Articles

Just released: December’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

Investing Articles

£9k in an ISA? Here are 2 FTSE 100 stocks to consider for a juicy second income

There are plenty of quality UK shares to consider when attempting to build a second income. Here are two high-yielders…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

No savings at 40? Just £5 a day invested in FTSE 250 stocks could unlock a £372k ISA

For the price of a coffee, Brits have a chance to build a healthy nest egg for their retirement. Here's…

Read more »

Investing Articles

Can I buy Elon Musk’s SpaceX on the stock market?

SpaceX is hot property and its valuation is surging. Dr James Fox explains how investors can gain exposure to Elon…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

Considering an ISA for retirement? Here’s how investors could aim for £2,000 a month with dividend shares

Our writer outlines how a well-balanced portfolio of dividend shares in an ISA could lead to a decent stream of…

Read more »

Investing Articles

Here’s the BP share price forecast

BP's share price should be higher. That’s what analysts are saying, but things can move quickly in the hydrocarbons and…

Read more »

Investing Articles

Up 53% in 3 months! What’s fuelling the red-hot Burberry share price?

Harvey Jones is whooping it up as the dramatic Burberry share price recovery wipes out most of his losses in…

Read more »